MDxHealth SA expected to post a loss of 19 cents a share - Earnings Preview
MDxHealth SA <MDXH.OQ> expected to post a loss of 19 cents a share - Earnings Preview
MDxHealth SA MDXH.OQ MDXH.O is expected to show a fall in quarterly revenue when it reports results on August 13 for the period ending June 30 2026
The Herstal Wallonia-based company is expected to report a 2.7% decrease in revenue to $25.884 million from $26.61 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
LSEG's mean analyst estimate for MDxHealth SA is for a loss of 19 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for MDxHealth SA is $3.00, about 560.8% above its last closing price of $0.45
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2026 | -0.15 | -0.15 | -0.17 | Missed | -11.8 |
Dec. 31 2026 | -0.13 | -0.13 | -0.17 | Missed | -34.9 |
Sep. 30 2025 | -0.13 | -0.11 | -0.16 | Missed | -48.1 |
Jun. 30 2025 | -0.14 | -0.12 | -0.15 | Missed | -21 |
Mar. 31 2025 | -0.13 | -0.13 | -0.19 | Missed | -46.2 |
Dec. 31 2024 | -0.18 | -0.19 | -0.14 | Beat | 27.1 |
Sep. 30 2024 | -0.28 | -0.27 | -0.40 | Missed | -48.1 |
Jun. 30 2024 | -0.27 | -0.26 | -0.42 | Missed | -58.5 |
This summary was machine generated August 11 at 20:37 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)